Growing Cannabis Market: M&A
Activity Plays Key Role; Fourth Preview of #Cannabis/ #Hemp #Stock Directory
Released
Investorideas.com – February 8, 2017 –
Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks, releases its fourth excerpt of its cannabis /hemp
stock directory for investors following the high profile sector.
Grand View Research says “The growing number of
mergers and acquisitions in the medical cannabis industry is one of the key
attributes that is expected to boost the market over the coming few years. Some
of the recent M&A activities in 2016 are as follows: • Nexus Corporation was acquired by Gibraltar
Industries, Cannabase entered into a partnership with BioTrackTHC. ”
U.S. medical marijuana market
by application, 2013 - 2025 (USD Billion)
Marijuana/Hemp Stock
List 2017
NEUTRA
CORPORATION (OTC:NTRR) is
a healthy lifestyle company that specializes in the development and marketing
of natural wellness solutions, including cannabis-related products.
New Age Farm Inc. (CSE: NF; OTC: NWGFF) is
in the business of providing fully built out turnkey farming solutions for
growers of high value luxury crops. We have operations in Washington State and
British Columbia and are interested in bringing our innovative model to other
jurisdictions with legalized medical and/or recreational marijuana.
Next
Generation Management Corp (OTC:NGMC) focuses, primarily,
on the acquisition of retail and cultivation licenses in the medical marijuana
industry. The Company’s overarching strategy is to acquire lines of business
that have high intrinsic future value and to generate existing, reliable
revenue streams, with the medical marijuana industry being its most recent and
promising direction. With this expanded direction, the Company has formed a
wholly owned subsidiary, NextGen Cannabis Consulting LLC to provide management
services to the high growth, high profit medical marijuana industry. NextGen
Cannabis Consulting is intent on the development of a national brand that
encompasses every aspect of the medical marijuana industry, including
collectives, dispensaries, and grow-ops. NextGen Holdings, LLC: Next Generation
Management Corporation's wholly-owned subsidiary was formed to hold its Oregon
cannabis assets.
Northsight Capital Inc. (OTC:NCAP) is comprised of a portfolio
of online marijuana-related websites that are being developed and operated by
the company. These sites incorporate many aspects of the marijuana industry.
The company provides its audience with a means to stay informed on the industry's
most cutting edge marijuana-related innovations and legislation. The company's
most dynamic concept, WeedDepot.com, provides consumers with a geo-targeted map
directory of medical and recreational dispensaries, head shops, doctors,
attorneys and more within the marijuana industry. The Weed Depot app can be
downloaded for free at the iTunes Store and Google Play. Weed Depot has an
entire platform of content suited for every aspect of advertising and marketing
to consumers from all businesses in the cannabis industry. Northsight's
current websites include: www.Weeddepot.com, www.420careers.com, www.MJBizwire.com, www.MarijuanaRecipes.com, www.RateMyStrain.com, www.WikiWeed.com, www.MarijuanaMd.com, and www.MarijuanaHealthTips.com
Notis Global, Inc (OTC:NGBL) Based in Los Angeles,
Notis Global is a pioneer in the burgeoning, multi-billion dollar legal hemp
industry. The Company and its partners are working to grow confidence and
generate revenues in the hemp industry. Through our key partnership with Folium
Biosciences, one of the largest hemp operations in the U.S., Notis is a leading
provider and distributor of cannabidiol (CBD).
NOVUS Acquisition
& Devleopment Corp. (OTC:NDEV) provides
health insurance and related insurance solutions to the medical marijuana
industry in states where legal programs exist. The Company also plans to offer
physicians' education programs, pharmaceutical R&D, compliance, and
business development services within the industry.
Nutritional
High International Inc. (CSE:EAT; OTCQB:SPLIF; FRANKFURT:2NU.F) is focused on
developing, manufacturing and distributing products and nationally recognized
brands in the hemp and marijuana-infused products industries, including edibles
and oil extracts for nutritional, medical and adult recreational use. The
Company works exclusively through licensed facilities in jurisdictions where
such activity is permitted and regulated by state law.
Omnicanna
Health (formerly Endocan) (OTC:ENDO) is
currently developing new natural cannabis-based products based on innovative
formulations to utilize the unique and potent benefits of the cannabis and hemp
plants. Medicinal properties of cannabis and hemp have been known and applied
for thousands of years. With the aid of scientific research, OmniCanna Health
Solutions is translating such knowledge into development of effective cannabinoid
formulation-based health and wellness solutions as well as cosmeceutical,
nutraceutical, and food brands throughout the world. The Company's health and
wellness, nutritional, and cosmetics lines will address personal needs and will
evolve with the introduction of new formulations and products, advancing the
Company within the expanding multibillion-dollar global market.
OrganiGram Holdings
Inc. (TSX:OGI.V) wholly owned
subsidiary, Organigram Inc., is a licensed producer of medical marijuana in
Canada. Organigram is focused on producing the highest quality, condition
specific medical marijuana for patients in Canada. Organigram's facility is
located in Moncton, New Brunswick and the Company is regulated by the Marihuana
for Medical Purposes Regulations.
OWC Pharmaceutical
Research Corp. (OTC:OWCP) through its wholly-owned Israeli subsidiary, One Word
Cannabis Ltd., (collectively \"OWC\" or the \"Company\")
conducts medical research and clinical trials to develop cannabis-based
pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis,
fibromyalgia, PTSD, and migraines. OWC is also developing unique delivery
systems for the effective delivery and dosage of medical cannabis. All OWC
research is conducted at leading Israeli hospitals and scientific institutions,
and led by internationally renowned investigators. The Company's Research
Division is focused on pursuing clinical trials evaluating the effectiveness of
cannabinoids for the treatment of various medical conditions, while its
Consulting Division is dedicated to helping governments and companies navigate
complex international cannabis regulatory frameworks.
Pazoo, Inc. (OTC:PZOO)
is a company focused on health, wellness and safety. Our focus is to
provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities,
contaminants and other irregularities. Through our wholly owned subsidiary,
Harris Lee, and our partnership with MA & Associates, Pazoo provides
industry leading laboratory testing of cannabis. Pazoo's license agreement with
Steep Hill Labs Inc. allows us to use their best-in-market testing protocols on
a right of first refusal basis as we expand throughout the USA. Pazoo is
licensed to test cannabis in Nevada and Oregon, with a focus on expansion into
other states. Additionally, Pazoo delivers a comprehensive array of health and
wellness information on its website www.pazoo.com, and features
industry experts from both the health and wellness arena and the pet industry.
Pharmacyte Bioetch (OTC:PMCB) (Formerly Nuvilex, Inc) is a clinical stage biotechnology
company focused on developing and preparing to commercialize treatments for
cancer and diabetes based upon a proprietary cellulose-based live cell
encapsulation technology known as Cell-in-a-Box®
This unique and patented technology will be used as a platform upon which
treatments for several types of cancer, including advanced, inoperable
pancreatic cancer, and diabetes are being built. PharmaCyte Biotech's treatment
for pancreatic cancer involves low doses of the well-known anticancer prodrug
ifosfamide, together with encapsulated live cells, which convert ifosfamide
into its active or "cancer-killing" form. These capsules are placed
as close to the cancerous tumor as possible to enable the delivery of the
highest levels of the cancer-killing drug at the source of the cancer. This
"targeted chemotherapy" has proven remarkably effective in past
clinical trials. In addition, PharmaCyte Biotech is working towards improving
the quality of life for patients with advanced pancreatic cancer and on treatments
for other types of solid cancerous tumors. PharmaCyte Biotech is also
developing treatments for cancer based upon chemical constituents of marijuana
known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to
exploit the benefits of Cell-in-a-Box® technology
in optimizing the anticancer effectiveness of cannabinoids, while minimizing or
outright eliminating the debilitating side effects usually associated with
cancer treatments. This provides PharmaCyte Biotech the rare opportunity to
develop "green" approaches to fighting deadly diseases, such as
cancer of the pancreas, brain and breast, which affect hundreds of thousands of
individuals worldwide every year.
Pineapple Express Inc. (OTC:PNPL) Headquartered in Los Angeles, Calif.,
Pineapple Express is a publicly traded company that invests in, expands, and
brands existing and newly established canna-businesses through expert consulting
and cutting-edge technology. We provide capital to our canna- business
clientele, lease real properties to canna-businesses, and provide consulting
and technology to operators within the cannabis industry. We intend to create a
nationally branded chain of company owned cannabis retail stores under the
"Pineapple Express" name, as soon as federal laws allow. As long as
cannabis remains federally illegal our operations will be limited to
consulting, product licensing, leasing to and investing in existing and new
canna-businesses, selling industry specific technology, and branding/retail
concept support services. Home to some of the most experienced and
well-connected minds in the business, Pineapple Express is at the forefront of
the legal cannabis industry.
Plandaà Biotechnology,
Inc.
(OTC:PLPL) and its subsidiaries
develop highly bioavailable, phytonutrient rich extracts which are being
utilized to deliver a new family of drugs to safely and affordably treat a
multitude of diseases and conditions. Plandaà Biotechnology controls every
aspect of the process, from growing the raw materials on its farms in South
Africa, to producing its proprietary Phytofare™ extracts in-house, allowing the
Company to guarantee the continuity of supply as well as quality control
throughout the entire process. Targeted industries for the Company's products
include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical.
Players Network Inc (OTC:PNTV) is a diversified company with
holdings in Media and Medical Marijuana. The Company uses its proprietary
Enterprise Web Platform to develop Branded Digital Lifestyle Television
Networks for itself and its partners in a wide range of lifestyle categories.
Player's Network's current original channels, "Player's Network,"
"Vegas on Demand," "Real Vegas TV," focus on the Las Vegas
and Gaming Lifestyles. These channels are distributed over PNTV's owned and
operated VOD Channels over its Broadband Network and Mobile Platforms. The
Medical Marijuana assets are primarily through the Company's 86% ownership in
Greenleaf Farms Holdings, and PNTV's newest channel, WeedTV.com, which focuses on the
rapidly expanding cannabis community.
Profile Solutions,
Inc. (OTC:PSIQ) designs, manufactures
and sells security-based identification products and systems that incorporate
state-of-the-art security technology to verify a person's identity, or grant
physical access. PSI has developed turnkey integrated applications that
incorporate our proprietary Access-It hardware platform. We also
integrate our applications with biometric technology for additional security
when required. PSI targets the law enforcement, cannabis industry and corporate America as our customer base.
PUF Ventures Inc. (CSE:PUF) is moving into the
Medical Marijuana sector by purchasing a 100% interest in AAA Heidelberg, a
private Ontario company that is in the process of applying for a MMPR license.
Although the Company cannot guarantee nor estimate the timing for the issuance
of a license to AAA Heidelberg, it is PUF’s goal to become the next publicly
traded Canadian company to be granted a new medical marijuana production
license. VapeTronix, a wholly owned subsidiary of the Company, is in the
process of expanding its 1313 brand of electronic cigarettes and associated
technologies.
Puget
Technologies, Inc. (OTC: PUGE) is a development-stage company. The Company is engaged in developing and
marketing of consumer-oriented products ready for commercialization. The
Company's subsidiaries include B-29 Energy, Inc. (B-29), which is in the
development stage. B-29 is engaged in the business of development and
distribution of energy products. B-29's products include B-29 Energy Drink and
various medical marijuana products, which are under development. B-29 produces
these products through its subsidiary, Cannabis Biotech. The Company is also
engaged in the development of three dimensional (3D) printing and supporting
technologies for My3DP personal printer. The applications of the Company's
products are in various sectors, which include crafting, jewelry and domestic
goods.
Radient Technologies
Inc. (TSX:RTI.V) extracts natural compounds from a range of biological
materials using microwave assisted processing ("MAP™"), a patented
technology platform which provides superior customer outcomes in terms of
ingredient purity, yield, and cost. From its 20,000 square foot manufacturing
plant in Edmonton, Alberta, Radient serves market leaders in industries that
include pharmaceutical, food, beverage, natural health, personal care and
biofuel markets. Marijuana – November 14 press release announces
foray in the fast emerging cannabinoids medical market.
Rapid Fire Marketing, Inc. (OTC:RFMK) is a developer and
reseller of herbal vaporizers. The core strategy is to maximize revenues in the
rapidly expanding medical cannabis and vaporizer industries. Rapid Fire
Marketing also looks to invest and do joint ventures with companies in the
vaporizer and medical cannabis industries as well as working with other
companies with established revenue streams that are looking to grow their
businesses. Rapid Fire Marketing is also looking to grow through acquisitions
of companies or technologies that are synergistic with our business plan.
RespireRx
Pharmaceuticals Inc. (OTCQB:
RSPI) is a leader in the development of
medicines for respiratory disorders, with a focus on sleep apneas and
drug-induced respiratory depression. The Company holds exclusive licenses and
owns patents and patent applications or rights thereto for certain families of
chemical compounds that claim the chemical structures and their uses in the
treatment of a variety of disorders, as well as claims for novel uses of known
drugs. RespireRx has a pipeline of medicines in Phase 2 clinical development
focused on pharmaceutical treatments for a variety of breathing disorders.
Clinical development in the area of respiratory disorders, particularly
drug-induced respiratory depression and sleep apnea, has created opportunities
for the development and commercialization of the Company's compounds. Cannabinoids. One platform being
developed by RespireRx is the class of compounds known as cannabinoids,
including dronabinol. Under a license agreement with the University of
Illinois, the Company has rights to patents claiming the use of cannabinoids
for the treatment of sleep-related breathing disorders. Ampakines. The other
platform of proprietary medicines being developed by RespireRx are ampakines,
which act to enhance the actions of the excitatory neurotransmitter glutamate
at AMPA glutamate receptors. Several ampakines, in both oral and injectable
forms, are being developed by the Company for the treatment of a variety of breathing
disorders. In clinical studies, select ampakines have shown preliminary
efficacy in central sleep apnea and in the control of respiratory depression
produced by opioids, without altering the opioid analgesic effects. In animal
models of orphan disorders, such as Pompe Disease, spinal cord injury and
perinatal respiratory distress, it has been demonstrated that certain ampakines
improve breathing function. The Company's compounds belong to a new class that
does not display the undesirable side effects previously reported for other
ampakines.
Rocky Mountain High Brands Inc (OTC:RMHB) is a consumer goods company
specializing in brand development of health conscious, hemp-infused food and
beverage products. The Company currently markets a lineup of four naturally
flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and
Lemonade) and a low-calorie Coconut Lime Energy drink. Rocky Mountain High
Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy
Shots, as well as a new Relaxation Brownie. The Company recently launched a
naturally high alkaline spring water, Eagle Spirit Spring Water™.
This directory is for research purposes and not a
solicitation to buy or sell securities.
To be added to the directory or update your description,
please call or email us.
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, company profiles,
interviews and more in leading sectors.
Sectors we cover in include tech, bitcoin and
blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana
and hemp stocks, food and beverage (including organic and LOHAS, wine), defense
and security including biometrics, Latin America, sports, entertainment, luxury
brands and gaming.
Follow stocks in your favourite stock sector
including marijuana and hemp stocks with Investor Ideas stock directories
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. PSIQ is a paid PR and news client on Investorideas – more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and
global Investors: Effective September 15 2008 - all BC investors should review
all OTC and Pink sheet listed companies for adherence in new disclosure filings
and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Contact Investorideas.com
800-665-0411
Marijuana / Hemp Stocks
Get the latest Cannabis and Hemp stock news from www.investorideas.com
